Observational Serial Chart Review of Repatha Use in European Subjects With Hyperlipidaemia

Trial Profile

Observational Serial Chart Review of Repatha Use in European Subjects With Hyperlipidaemia

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2017

At a glance

  • Drugs Evolocumab (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 11 Sep 2017 Planned End Date changed from 27 Dec 2019 to 24 Jun 2021.
    • 11 Sep 2017 Planned primary completion date changed from 27 Dec 2019 to 24 Jun 2021.
    • 02 Nov 2016 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top